HomeLPCN • NASDAQ
add
Lipocine Inc
Previous close
$3.27
Day range
$3.26 - $3.37
Year range
$2.52 - $5.50
Market cap
18.32M USD
Avg Volume
44.07K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 114.57K | — |
Operating expense | 3.48M | 32.13% |
Net income | -3.19M | -43.63% |
Net profit margin | -2.78K | — |
Earnings per share | — | — |
EBITDA | -3.35M | -27.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.13M | -23.67% |
Total assets | 16.07M | -22.35% |
Total liabilities | 1.93M | 22.13% |
Total equity | 14.14M | — |
Shares outstanding | 5.55M | — |
Price to book | 1.25 | — |
Return on assets | -48.50% | — |
Return on capital | -53.05% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.19M | -43.63% |
Cash from operations | -2.99M | -5.39% |
Cash from investing | 701.45K | -31.40% |
Cash from financing | 141.33K | — |
Net change in cash | -2.14M | -18.37% |
Free cash flow | -1.77M | 14.76% |
About
Founded
1997
Headquarters
Website
Employees
16
